Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inti Zlobec

Showing results (51-60 of 260) with videos related to

Pageof 26
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathwayKristi Baker, Inti Zlobec, Luigi Tornillo, et al.
Cancer|June 24, 2010
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastasesEva Karamitopoulou, Inti Zlobec, Anna Koumarianou, et al.
BMC Cancer|April 18, 2015
Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort studyViktor H Koelzer, Pia Herrmann, Inti Zlobec, et al.
Radiation Oncology (London, England)|November 25, 2015
Dose escalated intensity modulated radiotherapy in the treatment of cervical cancerNikola Cihoric, Alexandros Tsikkinis, Coya Tapia, et al.
Journal of Translational Medicine|December 17, 2013
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)Eva Karamitopoulou, Inti Zlobec, Beat Gloor, et al.
Histopathology|September 28, 2019
Tumour budding/T cell infiltrates in colorectal cancer: proposal of a novel combined scoreHeather Dawson, Lucine Christe, Micha Eichmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2012
Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancerOlivier T Giger, Sarah C M Comtesse, Alessandro Lugli, et al.
Human Pathology|February 15, 2011
Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancerCoya Tapia, Inti Zlobec, Sandra Schneider, et al.
Pathologie (Heidelberg, Germany)|November 21, 2023
National digital pathology projects in Switzerland: A 2023 updateRainer Grobholz, Andrew Janowczyk, Ana Leni Frei, et al.
Journal of Translational Medicine|August 28, 2015
Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancerLena Sokol, Viktor H Koelzer, Tilman T Rau, et al.
Pageof 26

Showing results (51-60 of 260) with videos related to

Sort By:
Pageof 26
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathwayKristi Baker, Inti Zlobec, Luigi Tornillo, et al.
Cancer|June 24, 2010
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastasesEva Karamitopoulou, Inti Zlobec, Anna Koumarianou, et al.
BMC Cancer|April 18, 2015
Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort studyViktor H Koelzer, Pia Herrmann, Inti Zlobec, et al.
Radiation Oncology (London, England)|November 25, 2015
Dose escalated intensity modulated radiotherapy in the treatment of cervical cancerNikola Cihoric, Alexandros Tsikkinis, Coya Tapia, et al.
Journal of Translational Medicine|December 17, 2013
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)Eva Karamitopoulou, Inti Zlobec, Beat Gloor, et al.
Histopathology|September 28, 2019
Tumour budding/T cell infiltrates in colorectal cancer: proposal of a novel combined scoreHeather Dawson, Lucine Christe, Micha Eichmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2012
Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancerOlivier T Giger, Sarah C M Comtesse, Alessandro Lugli, et al.
Human Pathology|February 15, 2011
Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancerCoya Tapia, Inti Zlobec, Sandra Schneider, et al.
Pathologie (Heidelberg, Germany)|November 21, 2023
National digital pathology projects in Switzerland: A 2023 updateRainer Grobholz, Andrew Janowczyk, Ana Leni Frei, et al.
Journal of Translational Medicine|August 28, 2015
Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancerLena Sokol, Viktor H Koelzer, Tilman T Rau, et al.
Pageof 26